| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10919407 | Radiotherapy and Oncology | 2011 | 5 Pages |
Abstract
This hypothesis generating study showed that high tumor levels of DNA-PK correlate with poor survival of GBM patients. Further studies are needed to confirm these results and to clarify whether DNA-PK inhibitors might have a potential to radiosensitize GBM and improve the treatment outcome of this devastating disease.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Marju Kase, Markus Vardja, Agu Lipping, Toomas Asser, Jana Jaal,